プロモーションスケジュール Centogene N.V.
詳細なスケジュール
簡易グラフ
会社について
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. さらに詳しくIPO date | 2019-11-07 |
---|---|
ISIN | NL0014040206 |
Industry | Health Care Providers & Services |
Sector | Health Care |
Валюта | usd |
Валюта отчета | eur |
Сайт | https://www.centogene.com |
Цена ао | 0.2238 |
1日あたりの価格変動: | 0% (0.1211) |
---|---|
週ごとの価格変動: | -9.9% (0.1344) |
月ごとの料金変更: | +34.56% (0.09) |
3ヶ月間の価格変動: | -39.45% (0.2) |
半年間の価格変動: | -70.32% (0.408) |
年間の価格変動: | -89.91% (1.2) |
3年間の価格推移: | -97.66% (5.17) |
5年間の価格推移: | -99.07% (13.05) |
10年間の価格推移: | 0% (0.1211) |
年初からの価格変動: | +28.15% (0.0945) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
機関 | 音量 | 共有, % |
---|---|---|
Platinum Investment Management Ltd | 2377150 | 8.61 |
Wells Fargo & Company | 206389 | 0.75 |
Acadian Asset Management. LLC | 24703 | 0.09 |
Blackrock Inc. | 21578 | 0.08 |
Millennium Management LLC | 19731 | 0.07 |
Morgan Stanley | 18231 | 0.07 |
Stifel Financial Corporation | 16450 | 0.06 |
Barclays PLC | 15348 | 0.06 |
Geode Capital Management, LLC | 11156 | 0.04 |
Meeder Asset Management, Inc. | 138 | 0 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Ms. Kim Stratton | CEO & Member of Management Board | 932.62k | 1962 (63 年) |
Mr. Jose Miguel Coego Rios | CFO, Legal & IT and Member of Management Board | 323.87k | 1974 (51 年) |
Dr. Peter Bauer M.D. | Interim MD, Chief Medical & Genomic Officer and Member of Management Board | 186.31k | 1970 (55 年) |
Dr. Andrin Oswald M.D., Ph.D. | Advisor | 943.45k | 1972 (53 年) |
Mr. Ian Rentsch | Chief Commercial Officer & GM of Pharma | N/A | 1976 (49 年) |